MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Monday, May 4, 2009

Natalizumab May Activate Oral Herpes Viruses

By Andrew N. Wilner, MD

SEATTLE, Wash -- May 3, 2009 -- Oral herpes virus (HSV-1) eruptions were 3 times more likely in patients with multiple sclerosis who were taking natalizumab than in multiple sclerosis patients on no therapy, according to research presented here at the American Academy of Neurology (AAN) 61st Annual Meeting.

Nicoline Schiess, MD, Johns Hopkins Medical Center, Baltimore, Maryland, and colleagues evaluated the activity of various herpes viruses in 34 patients with multiple sclerosis taking natalizumab and 34 age- and gender-matched healthy controls, as well as 20 patients with multiple sclerosis on no therapy and 20 patients with multiple sclerosis on interferon therapy. The results of their evaluation were presented here on April 28.

Continue reading this story from the doctors' guide

Have a Question, Comment or information for others? If so, please use the post comment link found below. Your name and email address would be appreciated but is not necessary unless you want a response from others. Thank You

No comments: